Coffee Interaction With the Antihypertensive Drug Felodipine
NCT ID: NCT02232269
Last Updated: 2018-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
13 participants
INTERVENTIONAL
2012-02-29
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Drug therapy plays a major role in the management of hypertension. However, the interaction between coffee or caffeine and blood pressure lowering drugs has been assessed in only three clinical studies that were reported more than three decades ago.
We conducted a comprehensive interaction study involving a commonly ingested amount of a particular Colombian coffee and felodipine in healthy middle-aged men and women. Peripheral (brachial) and central (aortic) hemodynamics and caffeine and felodipine pharmacokinetics were evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans
NCT01523028
Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?
NCT01526213
Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males
NCT02214290
Effects of Grape Juice With Breakfast on Glycemia and Cognitive Function in Healthy Adults
NCT03409497
Effects of Flavonoids on Cognitive Performance in Healthy Young Adults
NCT01312597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water plus Felodipine
Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Water
Felodipine
Black Coffee
Black Coffee, 300 ml, 0 and 1 hour
Black Coffee
Black Coffee plus Felodipine
Black Coffee, 300 ml, 0 and 1 hour
Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Black Coffee
Felodipine
Grapefruit Juice plus Felodipine
Grapefruit Juice, 300 ml, 0 and 1 hour
Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Grapefruit Juice
Felodipine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Black Coffee
Grapefruit Juice
Water
Felodipine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willingly signs ethics approved informed consent form
Exclusion Criteria
* significant illness within 2 weeks of starting study
* history of allergy to felodipine , tablet ingredients or dihydropyridines
* routinely taking prescription or OTC drugs or natural health products
* received an investigational drug withing the previous 4 weeks
* females who are pregnant or breast-feeding
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Bailey
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David G Bailey, BScPhm, PhD
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Victoria Clinical Trials Centre
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bailey DG, Dresser GK, Urquhart BL, Freeman DJ, Arnold JM. Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine. Am J Hypertens. 2016 Dec 1;29(12):1386-1393. doi: 10.1093/ajh/hpw081.
Dresser GK, Urquhart BL, Proniuk J, Tieu A, Freeman DJ, Arnold JM, Bailey DG. Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinically. Pharmacol Res Perspect. 2017 Oct;5(5):e00346. doi: 10.1002/prp2.346.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA-7122
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
R-11-655
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.